Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The EU AI Act: implications and compliance guidance for healthcare facilities.

Frontiers in digital health·2026
Same author

[SAKK 09/10: dose-intensified salvage radiotherapy for biochemical recurrence after prostatectomy-no benefit, but additional toxicity?]

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2026
Same author

In Reply to Sengul I and Sengul D.

Advances in radiation oncology·2026
Same author

PSA persistence in the PSMA PET era: reassessing a risk factor after radical prostatectomy.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Proton Beam Therapy in Prostate Cancer: Clinical Evidence, Controversies and Future Directions.

Archivos espanoles de urologia·2026
Same author

Global Disparities and Trends in Radiotherapy for Early-Stage Glottic Cancer.

Current oncology (Toronto, Ont.)·2026
Same journal

Effect of a Multidimensional Digital Health Intervention on Quality of Life in Breast Cancer Survivors: A Randomized Controlled Trial.

JCO clinical cancer informatics·2026
Same journal

Can Small Open-Source Language Models With Retrieval-Augmented Generation Match GPT-4 Performance in Breast Cancer Clinical Decision Support?

JCO clinical cancer informatics·2026
Same journal

Machine Learning Algorithm for the Detection of Tumor Microsatellite Instability Based on Multiomics Biomarkers.

JCO clinical cancer informatics·2026
Same journal

Foundation Model-Driven Regions of Interest Classification and Renaming in Cancer Radiotherapy: A Customizable, Retraining-Free Workflow Across Institutions.

JCO clinical cancer informatics·2026
Same journal

Announcing a New Article Type in <i>JCO Clinical Cancer Informatics</i>: The Resource Report.

JCO clinical cancer informatics·2026
Same journal

A Harmonized International Database of More Than 10,000 Pediatric Renal Tumor Patients From 30 Years of SIOP-RTSG Studies.

JCO clinical cancer informatics·2026
See all related articles

Related Experiment Video

Updated: Jun 5, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Large Language Model-Based Classification of Case Report Abstracts: A Pilot Study on Interactions Between

Fabio Dennstädt1,2, Til Bobnar1, Alin Handra3

  • 1Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.

JCO Clinical Cancer Informatics
|June 3, 2026
PubMed
Summary
This summary is machine-generated.

Large language models (LLMs) effectively classify rare cancer treatment interactions from case reports. This automated approach aids knowledge discovery, even with smaller open-source models, for oncology research.

Related Experiment Videos

Last Updated: Jun 5, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Area of Science:

  • Biomedical Informatics
  • Oncology
  • Natural Language Processing

Background:

  • The increasing volume of oncology literature presents challenges for information extraction.
  • Automated tools are needed to curate clinically relevant data from case reports, especially rare treatment interactions.
  • Large language models (LLMs) show potential for such data extraction tasks.

Purpose of the Study:

  • To evaluate the performance of LLM-based systems in extracting clinically relevant information from case reports on radiotherapy (RT) and systemic therapy (ST) interactions.
  • To assess the utility of LLMs for curating scientific literature detailing rare treatment interactions in oncology.

Main Methods:

  • Systematic PubMed search for case reports on RT interactions with pembrolizumab, cetuximab, or cisplatin.
  • Manual classification of 100 abstracts per therapy by two experts to establish ground truth.
  • Application of open-source Generative Pretrained Transformer (GPT) models (GPT-OSS-120B and GPT-OSS-20B) for classification.
  • Performance evaluation using accuracy, precision, recall, and F1-scores.

Main Results:

  • LLM-based classification (GPT-OSS-120B) achieved a high F1-score of 93.64% (95.19% accuracy).
  • Performance was consistent across different systemic therapies, with GPT-OSS-20B showing similar results (F1-score 93.22%).
  • Over 56% of publications involved patients receiving both RT and ST; outcome proportions varied by therapy and sequencing.

Conclusions:

  • LLM-based classification systems demonstrate high performance in curating scientific case reports on RT and ST interactions.
  • These systems show potential for high-throughput hypothesis generation and knowledge base construction.
  • Even smaller open-source LLMs are effective for this task, highlighting their value for underutilized case reports.